Subscribe
Subscribe
MY AMERICAN SCIENTIST
LOG IN! REGISTER!
SEARCH
 
Logo IMG
HOME > MULTIMEDIA > Multimedia Detail

SCIENCE IN THE NEWS DAILY

Vaccine Doubles Brain Cancer Survival Time

from the Guardian (UK)

A vaccine that more than doubles the survival time of patients with the most common and aggressive form of brain cancer has been developed by scientists.

Early results from clinical trials suggest patients who received the vaccine lived for nearly three years after being diagnosed with glioblastoma multiforme.

Patients given traditional anti-cancer treatment, including a combination of surgery, chemotherapy and radiotherapy, typically survived for a little more than a year following diagnosis. John Sampson, a neurosurgeon at Duke University's brain tumour centre in North Carolina, who led the trial, said: "We're more than doubling the survival time in this group, and we have some patients who are four, five or six years out from diagnosis, which is virtually unheard of in these people."

Read more ...


comments powered by Disqus
 

Connect With Us:

Facebook Icon Sm Twitter Icon Google+ Icon Pinterest Icon RSS Feed

Latest Multimedia

EmlenBookCover

VIDEO: From Biology to Military History: Patterns in Animal Weaponry

What are the parallels between an ancient war ship and a dung beetle? More than you would think, actually! Douglas J. Emlen, PhD, has a unique perspective on animal weaponry that looks at patterns in military history.

To view all multimedia content, click "Latest Multimedia"!



RSS Feed Subscription

Receive notification when new content is posted from the entire website, or choose from the customized feeds available.


EMAIL TO A FRIEND :

Of Possible Interest

Science In The News Daily: Diesel Exhausts Do Cause Cancer, Says WHO

Science in the News Weekly: T-DM1 Treats Breast Cancer With Fewer Side Effects

Science In The News Daily: CT Scans on Children 'Could Triple Brain Cancer Risk'

Subscribe to American Scientist